Trusted Messenger Intervention
Not Applicable
Terminated
- Conditions
- Vaccine Hesitancy
- Registration Number
- NCT05167422
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Brief Summary
The objective of this pilot study is to develop and evaluate test a trusted messenger intervention targeting vaccine hesitancy in patients on an inpatient psychiatric hospital setting with both acute and chronic patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 2
Inclusion Criteria
- Able and willing to give verbal informed consent to participate in the study or able to assent with guardian consent
- Expected to remain in the hospital for the duration of the study
- Mental health diagnosis Demographics
- Male, female, or transgender (no exclusion criteria based on gender or sexual orientation)
- Ages 18 or older
- Any race or ethnicity
- English speaking
Exclusion Criteria
- Cognitive impairment sufficient to interfere with participant's ability to provide assent
- People who are non-English speakers or who have major visual or hearing impairment will be excluded given the need to converse with the Trusted Messenger verbally
- People who have received any of the available forms of the COVID-19 vaccine, or those with a medical exemption for receiving the vaccine.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Vaccine acceptance- This will be measured using the COVID Vaccine Hesitancy Questionnaire Participant is willing to receive the vaccine by the end of week 6 of participation from baseline. The participant is willing to receive the COVID-19 vaccine
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
New Hampshire Hospital
🇺🇸Concord, New Hampshire, United States
New Hampshire Hospital🇺🇸Concord, New Hampshire, United States